Key Financial Inc
GSK icon

Key Financial Inc’s GSK GSK Stock Holding History

Key Financial Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$94.2K Buy
1,955
+1,395
+249% +$71.2K 0.02% 434
2026
Q2 		$29.4K Sell
560
-84
-13% -$4.44K ﹤0.01% 651
2026
Q1 		$35.5K Buy
644
+46
+8% +$2.49K 0.01% 607
2025
Q4 		$29.3K Hold
598
– – 0.01% 642
2025
Q3 		$27.2K Buy
598
+38
+7% +$1.48K 0.01% 645
2025
Q2 		$21.5K Buy
+560
New +$21.4K ﹤0.01% 677
2022
Q3 		– Sell
-861
Closed -$47K – 1140
2022
Q2 		$47K Hold
861
– – 0.03% 368
2022
Q1 		$47K Hold
861
– – 0.02% 370
2021
Q4 		$47K Hold
861
– – 0.02% 356
2021
Q3 		$41K Buy
861
+197
+30% +$9.9K 0.02% 365
2021
Q2 		$33K Hold
664
– – 0.02% 401
2021
Q1 		$30K Hold
664
– – 0.02% 344
2020
Q4 		$31K Buy
+664
New +$30.5K 0.02% 315
2020
Q2 		– Sell
-753
Closed -$35K – 309
2020
Q1 		$35K Buy
+753
New +$40.2K 0.04% 258

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Letko, Brosseau & Associates
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Key Financial Inc's GSK Position: Q3 2026 in Review

Key Financial Inc increased its GSK (GSK) stake by 249% in Q3 2026, buying an estimated $71.2K and bringing the position to 1,955 shares worth $94.2K. The position accounts for 0.02% of the portfolio, ranked #434.

Key Financial Inc first reported a position in GSK in Q1 2020 and has held it in 14 quarters since. 558 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Key Financial Inc held 1,955 shares of GSK worth $94.2K as of Q3 2026.
  • Key Financial Inc bought 1,395 GSK shares in Q3 2026, an estimated $71.2K.
  • GSK made up 0.02% of Key Financial Inc's portfolio in Q3 2026, its #434 holding.
  • Key Financial Inc first reported a position in GSK in Q1 2020 and has held it in 14 quarters since.
  • 558 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Key Financial Inc's 13F filing for Q3 2026, filed 2 Nov 2026.